Deciphering non-alcoholic fatty liver disease through metabolomics

Biochemical Society Transactions

Volumn 42, Issue 5, 2014, Pages 1447-1452

  Cano, Ainara ^a   Alonso, Cristina ^a  

^a OWL   (Spain)

Author keywords

Membrane; Metabolomics; Non alcoholic fatty liver disease (NAFLD); Phosphatidylcholine; Phosphatidylethanolamine; Steatohepatitis.

Indexed keywords

ALANINE AMINOTRANSFERASE; ARACHIDONIC ACID; BIOLOGICAL MARKER; CHOLINE; DOCOSAHEXAENOIC ACID; FAT DROPLET; GLYCINE METHYLTRANSFERASE; METHIONINE ADENOSYLTRANSFERASE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; S ADENOSYLMETHIONINE; SATURATED FATTY ACID; SPHINGOMYELIN; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; AUTOPHAGY; BIOGENESIS; BIOPHYSICS; CELL MEMBRANE; DIET SUPPLEMENTATION; ENDOPLASMIC RETICULUM MEMBRANE; ENDOPLASMIC RETICULUM STRESS; ENDOTOXEMIA; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GLYCINE METHYLTRANSFERASE GENE; HUMAN; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID MEMBRANE; LIPID STORAGE; LIPOGENESIS; LIPOPROTEIN METABOLISM; LIPOPROTEIN SECRETION; LIVER; LIVER BIOPSY; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; MAMMAL CELL; MASS SPECTROMETRY; MAT1A GENE; MEMBRANE FLUIDITY; METABOLIC PARAMETERS; METABOLOME; METABOLOMICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PARTIAL HEPATECTOMY; PATHOGENESIS; PHENOTYPE; PHOSPHATIDYLCHOLINE PHOSPHATIDYLETHANOLAMINE RATIO; REVIEW; SURVIVAL RATE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; BIOLOGICAL MODEL; BLOOD; CELL MEMBRANE PERMEABILITY; DISEASE COURSE; ENZYMOLOGY; LIPID METABOLISM; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; SECRETION (PROCESS);

ANIMALS; BIOLOGICAL MARKERS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DISEASE PROGRESSION; HUMANS; LIPID METABOLISM; LIPOPROTEINS, VLDL; LIVER; METABOLOMICS; MODELS, BIOLOGICAL; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84907188407     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20140138     Document Type: Review

References (57)

1. Wang, D.Q., Portincasa, P. and Neuschwander-Tetri, B.A. (2013) Steatosis in the liver. Compr. Physiol. 3, 1493-1532 CrossRef PubMed
2. Choi, S.S. and Diehl, A.M. (2008) Hepatic triglyceride synthesis and nonalcoholic fatty liver disease. Curr. Opin. Lipidol. 19, 295-300 CrossRef PubMed
3. Day, C.P. and James, O.F. (1998) Steatohepatitis: a tale of two 'hits'? Gastroenterology 114, 842-845 CrossRef PubMed
4. Bellentani, S., Scaglioni, F., Marino, M. and Bedogni, G. (2010) Epidemiology of non-alcoholic fatty liver disease. Dig. Dis. 28, 155-161 CrossRef PubMed
5. Schwenger, K.J. and Allard, J.P. (2014) Clinical approaches to non-alcoholic fatty liver disease. World J. Gastroenterol. 20, 1712-1723 CrossRef PubMed
6. Vance, D.E. and Vance, J.E. (2009) Physiological consequences of disruption of mammalian phospholipid biosynthetic genes. J. Lipid. Res. 50 (suppl), S132-S137 CrossRef PubMed
7. van Meer, G., Voelker, D.R. and Feigenson, G.W. (2008) Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112-124 CrossRef PubMed
8. van Meer, G. and de Kroon, A.I. (2011) Lipid map of the mammalian cell. J. Cell. Sci. 124, 5-8 CrossRef PubMed
9. Whiley, L., Sen, A., Heaton, J., Proitsi, P., Garcia-Gomez, D., Leung, R., Smith, N., Thambisetty, M., Kloszewska, I., Mecocci, P. et al. (2014) Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease. Neurobiol. Aging 35, 271-278 CrossRef PubMed
10. Feingold, K.R. and Elias, P.M. (2014) Role of lipids in the formation and maintenance of the cutaneous permeability barrier. Biochim. Biophys. Acta 1841, 280-294 CrossRef PubMed
11. Singh, R. and Cuervo, A.M. (2012) Lipophagy: connecting autophagy and lipid metabolism. Int. J. Cell. Biol. 2012, 282041 CrossRef PubMed
12. Cortez-Pinto, H., de Moura, M.C. and Day, C.P. (2006) Non-alcoholic steatohepatitis: from cell biology to clinical practice. J. Hepatol. 44, 197-208 CrossRef PubMed
13. Li, Z., Agellon, L.B., Allen, T.M., Umeda, M., Jewell, L., Mason, A. and Vance, D.E. (2006) The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 3, 321-331 CrossRef PubMed
14. Noga, A.A. and Vance, D.E. (2003) A gender-specific role for phosphatidylethanolamine N-methyltransferase-derived phosphatidylcholine in the regulation of plasma high density and very low density lipoproteins in mice. J. Biol. Chem. 278, 21851-21859 CrossRef PubMed
15. Brunt, E.M. (2001) Nonalcoholic steatohepatitis: definition and pathology. Semin. Liver Dis. 21, 3-16 CrossRef PubMed
16. Ling, J., Chaba, T., Zhu, L.F., Jacobs, R.L. and Vance, D.E. (2012) Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice. Hepatology 55, 1094-1102 CrossRef PubMed
17. Cui, Z. and Houweling, M. (2002) Phosphatidylcholine and cell death. Biochim. Biophys. Acta 1585, 87-96 CrossRef PubMed
18. Bigay, J. and Antonny, B. (2012) Curvature, lipid packing, and electrostatics of membrane organelles: defining cellular territories in determining specificity. Dev. Cell 23, 886-895 CrossRef PubMed
19. Fu, S., Yang, L., Li, P., Hofmann, O., Dicker, L., Hide, W., Lin, X., Watkins, S.M., Ivanov, A.R. and Hotamisligil, G.S. (2011) Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473, 528-531 CrossRef PubMed
20. Vance, D.E. (2008) Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis. Curr. Opin. Lipidol. 19, 229-234 CrossRef PubMed
21. Gibbons, G.F., Wiggins, D., Brown, A.M. and Hebbachi, A.M. (2004) Synthesis and function of hepatic very-low-density lipoprotein. Biochem. Soc. Trans. 32, 59-64 CrossRef PubMed
22. Welte, M.A. (2009) Fat on the move: intracellular motion of lipid droplets. Biochem. Soc. Trans. 37, 991-996 CrossRef PubMed
23. Horl, G., Wagner, A., Cole, L.K., Malli, R., Reicher, H., Kotzbeck, P., Kofeler, H., Hofler, G., Frank, S., Bogner-Strauss, J.G., Sattler, W. et al. (2011) Sequential synthesis and methylation of phosphatidylethanolamine promote lipid droplet biosynthesis and stability in tissue culture and in vivo. J. Biol. Chem. 286, 17338-17350 CrossRef PubMed
24. Mato, J.M. and Lu, S.C. (2007) Role of S-adenosyl-l-methionine in liver health and injury. Hepatology 45, 1306-1312 CrossRef PubMed
25. Anstee, Q.M. and Day, C.P. (2012) S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility. J. Hepatol. 57, 1097-1109 CrossRef PubMed
26. Varela-Rey, M., Woodhoo, A., Martinez-Chantar, M.L., Mato, J.M. and Lu, S.C. (2013) Alcohol, DNA methylation, and cancer. Alcohol Res. 35, 25-35 PubMed
27. Cano, A., Buque, X., Martinez-Una, M., Aurrekoetxea, I., Menor, A., Garcia-Rodriguez, J.L., Lu, S.C., Martinez-Chantar, M.L., Mato, J.M., Ochoa, B. and Aspichueta, P. (2011) Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice. Hepatology 54, 1975-1986 CrossRef PubMed
28. Martinez-Una, M., Varela-Rey, M., Cano, A., Fernandez-Ares, L., Beraza, N., Aurrekoetxea, I., Martinez-Arranz, I., Garcia-Rodriguez, J.L., Buque, X., Mestre, D. et al. (2013) Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis. Hepatology 58, 1296-1305 CrossRef PubMed
29. Jacobs, R.L., van der Veen, J.N. and Vance, D.E. (2013) Finding the balance: the role of S-adenosylmethionine and phosphatidylcholine metabolism in development of nonalcoholic fatty liver disease. Hepatology 58, 1207-1209 CrossRef PubMed
30. Cantoni, G.L. (1951) Activation of methionine for transmethylation. J. Biol. Chem. 189, 745-754 PubMed
31. Avila, M.A., Berasain, C., Torres, L., Martin-Duce, A., Corrales, F.J., Yang, H., Prieto, J., Lu, S.C., Caballeria, J., Rodes, J. and Mato, J.M. (2000) Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J. Hepatol. 33, 907-914 CrossRef PubMed
32. Duce, A.M., Ortiz, P., Cabrero, C. and Mato, J.M. (1988) S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 8, 65-68 CrossRef PubMed
33. Martinez-Chantar, M.L., Corrales, F.J., Martinez-Cruz, L.A., Garcia-Trevijano, E.R., Huang, Z.Z., Chen, L., Kanel, G., Avila, M.A., Mato, J.M. and Lu, S.C. (2002) Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J. 16, 1292-1294 PubMed
34. Aspichueta, P., Perez, S., Ochoa, B. and Fresnedo, O. (2005) Endotoxin promotes preferential periportal upregulation of VLDL secretion in the rat liver. J. Lipid Res. 46, 1017-1026 CrossRef PubMed
35. Ko, K., Yang, H., Noureddin, M., Iglesia-Ara, A., Xia, M., Wagner, C., Luka, Z., Mato, J.M. and Lu, S.C. (2008) Changes in S-adenosylmethionine and GSH homeostasis during endotoxemia in mice. Lab. Invest. 88, 1121-1129 CrossRef PubMed
36. Ridgway, N.D. and Vance, D.E. (1988) Kinetic mechanism of phosphatidylethanolamine N-methyltransferase. J. Biol. Chem. 263, 16864-16871 PubMed
37. DeLong, C.J., Shen, Y.J., Thomas, M.J. and Cui, Z. (1999) Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway. J. Biol. Chem. 274, 29683-29688 CrossRef PubMed
38. da Costa, K.A., Sanders, L.M., Fischer, L.M. and Zeisel, S.H. (2011) Docosahexaenoic acid in plasma phosphatidylcholine may be a potential marker for in vivo phosphatidylethanolamine N-methyltransferase activity in humans. Am. J. Clin. Nutr. 93, 968-974 CrossRef PubMed
39. Williams, K.T. and Schalinske, K.L. (2012) Tissue-specific alterations of methyl group metabolism with DNA hypermethylation in the Zucker (type 2) diabetic fatty rat. Diabetes Metab. Res. Rev. 28, 123-131 CrossRef PubMed
40. Buque, X., Martinez, M.J., Cano, A., Miquilena-Colina, M.E., Garcia-Monzon, C., Aspichueta, P. and Ochoa, B. (2010) A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats. J. Lipid Res. 51, 500-513 CrossRef PubMed
41. Hellmuth, C., Demmelmair, H., Schmitt, I., Peissner, W., Bluher, M. and Koletzko, B. (2013) Association between plasma nonesterified fatty acids species and adipose tissue fatty acid composition. PLoS ONE 8, e74927 CrossRef PubMed
42. Kotronen, A., Seppanen-Laakso, T., Westerbacka, J., Kiviluoto, T., Arola, J., Ruskeepaa, A.L., Yki-Jarvinen, H. and Oresic, M. (2010) Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Obesity 18, 937-944 CrossRef PubMed
43. Barr, J., Vazquez-Chantada, M., Alonso, C., Perez-Cormenzana, M., Mayo, R., Galan, A., Caballeria, J., Martin-Duce, A., Tran, A., Wagner, C. et al. (2010) Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. J. Proteome. Res. 9, 4501-4512 CrossRef PubMed
44. Bou Khalil, M., Hou, W., Zhou, H., Elisma, F., Swayne, L.A., Blanchard, A.P., Yao, Z., Bennett, S.A. and Figeys, D. (2010) Lipidomics era: accomplishments and challenges. Mass Spectrom. Rev. 29, 877-929 CrossRef PubMed
45. Fahy, E., Subramaniam, S., Murphy, R.C., Nishijima, M., Raetz, C.R., Shimizu, T., Spener, F., van Meer, G., Wakelam, M.J. and Dennis, E.A. (2009) Update of the LIPID MAPS comprehensive classification system for lipids. J. Lipid. Res. 50 (Suppl.), S9-S14 CrossRef PubMed
46. Wishart, D.S., Jewison, T., Guo, A.C., Wilson, M., Knox, C., Liu, Y., Djoumbou, Y., Mandal, R., Aziat, F., Dong, E. et al. (2013) HMDB 3.0: the human metabolome database in 2013. Nucleic Acids Res. 41, D801-D807 CrossRef PubMed
47. Nicholson, J.K. and Lindon, J.C. (2008) Systems biology: metabonomics. Nature 455, 1054-1056 CrossRef PubMed
48. Patti, G.J., Yanes, O. and Siuzdak, G. (2012) Innovation: metabolomics - the apogee of the omics trilogy. Nat. Rev. Mol. Cell Biol. 13, 263-269 CrossRef PubMed
49. Puri, P., Baillie, R.A., Wiest, M.M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M.J. and Sanyal, A.J. (2007) A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 46, 1081-1090 CrossRef PubMed
50. Puri, P., Wiest, M.M., Cheung, O., Mirshahi, F., Sargeant, C., Min, H.K., Contos, M.J., Sterling, R.K., Fuchs, M., Zhou, H. et al. (2009) The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 50, 1827-1838 CrossRef PubMed
51. Garcia-Canaveras, J.C., Donato, M.T., Castell, J.V. and Lahoz, A. (2011) A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations. J. Proteome Res. 10, 4825-4834 CrossRef PubMed
52. Barr, J., Caballeria, J., Martinez-Arranz, I., Dominguez-Diez, A., Alonso, C., Muntane, J., Perez-Cormenzana, M., Garcia-Monzon, C., Mayo, R., Martin-Duce, A. et al. (2012) Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J. Proteome. Res. 11, 2521-2532 CrossRef PubMed
53. Allard, J.P., Aghdassi, E., Mohammed, S., Raman, M., Avand, G., Arendt, B.M., Jalali, P., Kandasamy, T., Prayitno, N., Sherman, M. et al. (2008) Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J. Hepatol. 48, 300-307 CrossRef PubMed
54. Kalhan, S.C., Guo, L., Edmison, J., Dasarathy, S., McCullough, A.J., Hanson, R.W. and Milburn, M. (2011) Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism 60, 404-413 CrossRef PubMed
55. Moore, S., Matthews, C., Sampson, J., Stolzenberg-Solomon, R., Zheng, W., Cai, Q., Tan, Y., Chow, W.-H., Ji, B.-T., Liu, D. et al. (2014) Human metabolic correlates of body mass index. Metabolomics 10, 259-269 CrossRef
56. Alonso, C. and Mato, J.M. (2014) Nonalcoholic fatty liver disease. In Global Metabolic Profiling: Clinical Applications (Nicholls, A., Theodoridis, G. and Wilson, I.D., eds), pp. 110-122, Future Science Ltd, doi:10.4155/ebo.13.392
57. Arendt, B.M., Ma, D.W., Simons, B., Noureldin, S.A., Therapondos, G., Guindi, M., Sherman, M. and Allard, J.P. (2013) Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine. Appl. Physiol. Nutr. Metab. 38, 334-340 CrossRef PubMed